A detailed history of Northwestern Mutual Investment Management Company, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Northwestern Mutual Investment Management Company, LLC holds 22,462 shares of NBIX stock, worth $2.56 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
22,462
Previous 22,195 1.2%
Holding current value
$2.56 Million
Previous $3.06 Million 1.01%
% of portfolio
0.08%
Previous 0.08%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$130.86 - $143.19 $34,939 - $38,231
267 Added 1.2%
22,462 $3.09 Million
Q1 2024

May 15, 2024

BUY
$130.4 - $143.74 $43,944 - $48,440
337 Added 1.54%
22,195 $3.06 Million
Q4 2023

Feb 13, 2024

BUY
$106.07 - $132.76 $21,214 - $26,552
200 Added 0.92%
21,858 $2.88 Million
Q3 2023

Nov 14, 2023

SELL
$94.02 - $117.1 $2,538 - $3,161
-27 Reduced 0.12%
21,658 $2.44 Million
Q2 2023

Aug 14, 2023

BUY
$89.53 - $104.87 $22,919 - $26,846
256 Added 1.19%
21,685 $2.04 Million
Q1 2023

May 15, 2023

BUY
$94.11 - $123.02 $1.18 Million - $1.54 Million
12,532 Added 140.86%
21,429 $2.17 Million
Q4 2022

Feb 21, 2023

SELL
$106.72 - $127.06 $524,528 - $624,499
-4,915 Reduced 35.58%
8,897 $1.06 Million
Q3 2022

Nov 14, 2022

SELL
$92.03 - $107.81 $201,177 - $235,672
-2,186 Reduced 13.66%
13,812 $1.47 Million
Q2 2022

Aug 04, 2022

BUY
$75.79 - $100.07 $18,341 - $24,216
242 Added 1.54%
15,998 $1.56 Million
Q1 2022

May 09, 2022

BUY
$72.45 - $94.81 $2,173 - $2,844
30 Added 0.19%
15,756 $1.48 Million
Q4 2021

Feb 03, 2022

BUY
$79.65 - $106.22 $7,248 - $9,666
91 Added 0.58%
15,726 $1.34 Million
Q3 2021

Nov 15, 2021

SELL
$86.18 - $99.03 $9,565 - $10,992
-111 Reduced 0.7%
15,635 $1.5 Million
Q2 2021

Aug 13, 2021

BUY
$89.43 - $102.27 $12,162 - $13,908
136 Added 0.87%
15,746 $1.53 Million
Q1 2021

May 14, 2021

BUY
$87.57 - $119.4 $1.37 Million - $1.86 Million
15,610 New
15,610 $1.52 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $10.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Northwestern Mutual Investment Management Company, LLC Portfolio

Follow Northwestern Mutual Investment Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Investment Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Investment Management Company, LLC with notifications on news.